Skip to main content
Earnings Labs
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. (CMMB)

NASDAQ·Healthcare·Biotechnology

$1.68

-5.62%

Mkt Cap $12.31M

No analyst coverage available

We don't have analyst ratings or price target data for Chemomab Therapeutics Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.